New England Compounding Pharmacy, Inc. company research & investing information. Find executives and the latest company news.
Case Information: MDL 2419: In Re: New England Compounding Pharmacy, Inc., Products Liability Litigation . LEAD CASE NUMBER 1:13-md-2419. These actions share factual questions relating to injuries arising from the alleged contamination of the injectable steroid methyl-prednisolone acetate at the New England Compounding Pharmacy facility in ...
A New England Compounding Center meningitis outbreak that began in September 2012 sickened over 800 ... The compounding pharmacy industry had created ...
Parties, docket activity and news coverage of federal case In Re: New England Compounding Pharmacy, Inc. Products Liability Litigation, case number 1:13-md-02419, from Massachusetts Court.
Company profile & key executives for New England Compounding Pharmacy Inc (0659829D:-) including description, corporate address, management team and contact info.
New England Compounding Pharmacy, Inc. 697 Waverly St. Framingham, MA 01701 MIDDLESEX-MA Tax ID / EIN: xx-xxx7495 Represented By. Daniel C. Cohn Murtha Cullina LLP
NEW ENGLAND COMPOUNDING PHARMACY INC. 697 WAVERLY STREET FRAMINGHAM, MA 01702 El 4/9, 4/10, 4/16/02 CDS/KJ/ML PAGE2 Mr. Cadden was informed that the purpose for the inspection was a follow-up to
13-2419 - In Re: New England Compounding Pharmacy, Inc. Products Liability Litigation
Personal Injury: Health Care case filed on January 15, 2013 in the New Jersey District Court
- related to New England Compounding Pharmacy, Inc